Login to Your Account



Enzon Offloads Specialty Arm to Sigma-Tau for up to $327M

By Catherine Hollingsworth


Tuesday, November 10, 2009
Enzon Pharmaceuticals Inc. has agreed to sell its specialty pharmaceutical business to Italian-owned Sigma-Tau Pharmaceuticals Inc. for $300 million plus up to an additional $27 million based on milestones. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription